$VPHM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VIROPHARMA INC. Get notifications about new insider transactions in VIROPHARMA INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 3.14 | 60,000 | 188,400 | 262,444 | 202.4 K to 262.4 K (+29.64 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 3.55 | 100,000 | 355,000 | 202,444 | 102.4 K to 202.4 K (+97.61 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 2.09 | 30,000 | 62,700 | 102,444 | 72.4 K to 102.4 K (+41.41 %) |
Mar 07 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 3.93 | 20,000 | 78,600 | 72,444 | 52.4 K to 72.4 K (+38.14 %) |
Mar 06 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Sell | S | 32.99 | 30,000 | 989,700 | 42,881 | 72.9 K to 42.9 K (-41.16 %) |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 8.86 | 25,000 | 221,500 | 50,000 | |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 5.91 | 10,000 | 59,100 | 20,000 | |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | M | 11.96 | 35,000 | 418,600 | 65,000 | |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Sell | S | 32.11 | 12,750 | 409,434 | 17,125 | 29.9 K to 17.1 K (-42.68 %) |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Sell | S | 32.12 | 70,000 | 2,248,197 | 29,875 | 99.9 K to 29.9 K (-70.09 %) |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 8.86 | 25,000 | 221,500 | 99,875 | 74.9 K to 99.9 K (+33.39 %) |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 5.91 | 10,000 | 59,100 | 74,875 | 64.9 K to 74.9 K (+15.41 %) |
Mar 05 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | M | 11.96 | 35,000 | 418,600 | 64,875 | 29.9 K to 64.9 K (+117.15 %) |
Feb 28 2012 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Grant | A | 0.00 | 4,500 | 0 | 64,500 | 60 K to 64.5 K (+7.50 %) |
Feb 28 2012 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
Jan 06 2012 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 28.15 | 27,265 | 767,510 | 27,265 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
Feb 28 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Grant | A | 0.00 | 4,500 | 0 | 41,360 | 36.9 K to 41.4 K (+12.21 %) |
Feb 28 2012 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | A | 31.74 | 15,000 | 476,100 | 15,000 | |
Feb 28 2012 | VPHM | VIROPHARMA INC | Leone John R | Director | Grant | A | 0.00 | 4,500 | 0 | 6,500 | 2 K to 6.5 K (+225.00 %) |
Jan 06 2012 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 28.15 | 27,265 | 767,510 | 27,265 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | A | 28.15 | 27,265 | 767,510 | 27,265 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 28.15 | 27,265 | 767,510 | 27,265 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 28.15 | 27,265 | 767,510 | 27,265 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 28.15 | 36,890 | 1,038,454 | 36,890 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | A | 28.15 | 6,000 | 168,900 | 6,000 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 28.15 | 27,265 | 767,510 | 27,265 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 28.15 | 54,530 | 1,535,020 | 54,530 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 20.16 | 7,205 | 145,253 | 0 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 20.16 | 2,795 | 56,347 | 0 | |
Jan 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Payment of Exercise | F | 27.91 | 7,224 | 201,622 | 94,384 | 101.6 K to 94.4 K (-7.11 %) |
Jan 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 27.91 | 7,205 | 201,092 | 101,608 | 94.4 K to 101.6 K (+7.63 %) |
Jan 06 2012 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 27.91 | 2,795 | 78,008 | 94,403 | 91.6 K to 94.4 K (+3.05 %) |
Jan 04 2012 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | A | 0.00 | 6,250 | 0 | 6,250 | |
Jan 04 2012 | VPHM | VIROPHARMA INC | McHugh Julie | Director | Option Exercise | A | 27.99 | 12,500 | 349,875 | 12,500 | |
Jan 03 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Option Exercise | M | 22.99 | 1,300 | 29,887 | 0 | |
Jan 03 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Payment of Exercise | F | 27.93 | 1,131 | 31,589 | 169 | 1.3 K to 169 (-87.00 %) |
Jan 03 2012 | VPHM | VIROPHARMA INC | Fletcher Robert C. | V.P., Business Deve ... | Buy | M | 22.99 | 1,300 | 29,887 | 1,300 | 0 to 1.3 K |
Dec 27 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 1.84 | 17,500 | 32,200 | 130,000 | |
Dec 27 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 1.84 | 17,500 | 32,200 | 36,939 | 19.4 K to 36.9 K (+90.03 %) |
Dec 16 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 27.29 | 7,828 | 213,613 | 303,264 | 295.4 K to 303.3 K (+2.65 %) |
Dec 16 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 27.29 | 291,706 | 7,960,161 | 9,840,469 | 9.5 M to 9.8 M (+3.05 %) |
Dec 14 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 7.05 | 22,330 | 157,427 | 0 | |
Dec 14 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 7.05 | 17,670 | 124,574 | 22,330 | |
Dec 14 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 23.50 | 22,330 | 524,755 | 19,439 | 41.8 K to 19.4 K (-53.46 %) |
Dec 14 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 7.05 | 22,330 | 157,427 | 41,769 | 19.4 K to 41.8 K (+114.87 %) |
Dec 14 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 23.50 | 17,670 | 415,317 | 19,439 | 37.1 K to 19.4 K (-47.62 %) |
Dec 14 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 7.05 | 17,670 | 124,574 | 37,109 | 19.4 K to 37.1 K (+90.90 %) |
Dec 16 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 27.29 | 50,566 | 1,379,860 | 1,966,090 | 1.9 M to 2 M (+2.64 %) |
Dec 15 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 8.71 | 25,000 | 217,750 | 0 | |
Dec 15 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 8.71 | 25,000 | 217,750 | 25,000 | |
Dec 15 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 25.17 | 25,000 | 629,250 | 19,439 | 44.4 K to 19.4 K (-56.26 %) |
Dec 15 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 8.71 | 25,000 | 217,750 | 44,439 | 19.4 K to 44.4 K (+128.61 %) |
Dec 15 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 25.50 | 25,000 | 637,500 | 19,439 | 44.4 K to 19.4 K (-56.26 %) |
Dec 15 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 8.71 | 25,000 | 217,750 | 44,439 | 19.4 K to 44.4 K (+128.61 %) |
Dec 01 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 9.99 | 20,000 | 199,800 | 15,000 | |
Dec 01 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | S | 24.00 | 20,000 | 480,000 | 3,910 | 23.9 K to 3.9 K (-83.65 %) |
Dec 01 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 9.99 | 20,000 | 199,800 | 23,910 | 3.9 K to 23.9 K (+511.51 %) |
Dec 06 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 2.09 | 15,000 | 31,350 | 0 | |
Dec 06 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 0.99 | 1 | 1 | 0 | |
Dec 06 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.93 | 4 | 16 | 0 | |
Dec 06 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 2.09 | 15,000 | 31,350 | 91,213 | 76.2 K to 91.2 K (+19.68 %) |
Dec 06 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 0.99 | 1 | 1 | 76,213 | 76.2 K to 76.2 K (0.00 %) |
Dec 06 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.93 | 4 | 16 | 76,212 | 76.2 K to 76.2 K (+0.01 %) |
Dec 05 2011 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
Dec 05 2011 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Sell | S | 23.82 | 10,000 | 238,159 | 52,444 | 62.4 K to 52.4 K (-16.01 %) |
Dec 05 2011 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 20.16 | 10,000 | 201,600 | 62,444 | 52.4 K to 62.4 K (+19.07 %) |
Nov 28 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 9.99 | 1,000 | 9,990 | 54,000 | |
Nov 28 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | S | 23.00 | 1,000 | 23,000 | 2,910 | 3.9 K to 2.9 K (-25.58 %) |
Nov 28 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 9.99 | 1,000 | 9,990 | 3,910 | 2.9 K to 3.9 K (+34.36 %) |
Nov 29 2011 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | M | 3.00 | 5,000 | 15,000 | 20,000 | |
Nov 29 2011 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Sell | S | 23.00 | 5,000 | 115,000 | 36,860 | 41.9 K to 36.9 K (-11.94 %) |
Nov 29 2011 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Buy | M | 3.00 | 5,000 | 15,000 | 41,860 | 36.9 K to 41.9 K (+13.56 %) |
Nov 29 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 9.99 | 19,000 | 189,810 | 35,000 | |
Nov 29 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | S | 23.00 | 19,000 | 437,000 | 3,910 | 22.9 K to 3.9 K (-82.93 %) |
Nov 29 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 9.99 | 19,000 | 189,810 | 22,910 | 3.9 K to 22.9 K (+485.93 %) |
Nov 17 2011 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | M | 20.28 | 2,000 | 40,560 | 0 | |
Nov 17 2011 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Sell | S | 22.59 | 2,000 | 45,181 | 1,165 | 3.2 K to 1.2 K (-63.19 %) |
Nov 17 2011 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Buy | M | 20.28 | 2,000 | 40,560 | 3,165 | 1.2 K to 3.2 K (+171.67 %) |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.55 | 41,691 | 148,003 | 58,309 | |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 3.93 | 19,996 | 78,584 | 4 | |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 2.09 | 15,000 | 31,350 | 15,000 | |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | S | 22.53 | 41,691 | 939,127 | 76,208 | 117.9 K to 76.2 K (-35.36 %) |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.55 | 41,691 | 148,003 | 117,899 | 76.2 K to 117.9 K (+54.71 %) |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | S | 22.53 | 19,996 | 450,428 | 76,208 | 96.2 K to 76.2 K (-20.78 %) |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 3.93 | 19,996 | 78,584 | 96,204 | 76.2 K to 96.2 K (+26.24 %) |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | S | 22.53 | 15,000 | 337,889 | 76,208 | 91.2 K to 76.2 K (-16.45 %) |
Nov 23 2011 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 2.09 | 15,000 | 31,350 | 91,208 | 76.2 K to 91.2 K (+19.68 %) |
Nov 15 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | M | 8.86 | 20,000 | 177,200 | 80,000 | |
Nov 15 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Sell | S | 22.00 | 20,000 | 440,000 | 3,910 | 23.9 K to 3.9 K (-83.65 %) |
Nov 15 2011 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Buy | M | 8.86 | 20,000 | 177,200 | 23,910 | 3.9 K to 23.9 K (+511.51 %) |
Nov 08 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 5.91 | 20,000 | 118,200 | 20,000 | |
Nov 08 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 21.01 | 200 | 4,202 | 19,439 | 19.6 K to 19.4 K (-1.02 %) |
Nov 08 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 21.00 | 19,800 | 415,800 | 19,639 | 39.4 K to 19.6 K (-50.20 %) |
Nov 08 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 5.91 | 20,000 | 118,200 | 39,439 | 19.4 K to 39.4 K (+102.89 %) |
Nov 09 2011 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | M | 2.44 | 12,250 | 29,890 | 0 | |
Nov 09 2011 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Sell | S | 21.08 | 12,250 | 258,194 | 0 | 12.3 K to 0 (-100.00 %) |
Nov 09 2011 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Buy | M | 2.44 | 12,250 | 29,890 | 12,250 | 0 to 12.3 K |
Nov 02 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 3.14 | 24,121 | 75,740 | 0 | |
Nov 02 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | M | 3.14 | 20,495 | 64,354 | 24,121 | |
Nov 02 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 20.05 | 24,121 | 483,641 | 19,439 | 43.6 K to 19.4 K (-55.37 %) |
Nov 02 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 3.14 | 24,121 | 75,740 | 43,560 | 19.4 K to 43.6 K (+124.09 %) |
Nov 02 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Sell | S | 20.42 | 20,495 | 418,555 | 19,439 | 39.9 K to 19.4 K (-51.32 %) |
Nov 02 2011 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Buy | M | 3.14 | 20,495 | 64,354 | 39,934 | 19.4 K to 39.9 K (+105.43 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.18 | 16,278 | 295,985 | 1,915,524 | 1.9 M to 1.9 M (+0.86 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.48 | 2,511 | 43,883 | 1,899,246 | 1.9 M to 1.9 M (+0.13 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.18 | 145,763 | 2,650,423 | 9,548,763 | 9.4 M to 9.5 M (+1.55 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.48 | 45,584 | 796,644 | 9,403,000 | 9.4 M to 9.4 M (+0.49 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.18 | 6,017 | 109,408 | 295,436 | 289.4 K to 295.4 K (+2.08 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.48 | 1,905 | 33,293 | 289,419 | 287.5 K to 289.4 K (+0.66 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.08 | 3,367 | 60,874 | 287,514 | 284.1 K to 287.5 K (+1.18 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.19 | 1,645 | 29,927 | 284,147 | 282.5 K to 284.1 K (+0.58 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.00 | 6,084 | 109,507 | 282,502 | 276.4 K to 282.5 K (+2.20 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.97 | 3,423 | 61,497 | 276,418 | 273 K to 276.4 K (+1.25 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.71 | 445,574 | 7,890,269 | 9,357,416 | 8.9 M to 9.4 M (+5.00 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.62 | 70,629 | 1,244,589 | 8,911,842 | 8.8 M to 8.9 M (+0.80 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.08 | 88,657 | 1,602,892 | 8,841,213 | 8.8 M to 8.8 M (+1.01 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.19 | 43,321 | 788,122 | 8,752,556 | 8.7 M to 8.8 M (+0.50 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.00 | 159,945 | 2,878,882 | 8,709,235 | 8.5 M to 8.7 M (+1.87 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.97 | 89,970 | 1,616,392 | 8,549,290 | 8.5 M to 8.5 M (+1.06 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.08 | 13,576 | 245,450 | 1,896,735 | 1.9 M to 1.9 M (+0.72 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.19 | 6,634 | 120,690 | 1,883,159 | 1.9 M to 1.9 M (+0.35 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.00 | 21,117 | 380,089 | 1,876,525 | 1.9 M to 1.9 M (+1.14 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.97 | 11,878 | 213,399 | 1,855,408 | 1.8 M to 1.9 M (+0.64 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.13 | 4,697 | 85,155 | 1,843,530 | 1.8 M to 1.8 M (+0.26 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.13 | 22,084 | 400,295 | 1,838,833 | 1.8 M to 1.8 M (+1.22 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.78 | 8,828 | 156,988 | 1,816,749 | 1.8 M to 1.8 M (+0.49 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.74 | 25,753 | 456,750 | 1,807,921 | 1.8 M to 1.8 M (+1.45 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.58 | 2,147 | 37,753 | 1,782,168 | 1.8 M to 1.8 M (+0.12 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.43 | 9,340 | 162,759 | 1,780,021 | 1.8 M to 1.8 M (+0.53 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.13 | 28,000 | 507,632 | 8,459,320 | 8.4 M to 8.5 M (+0.33 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.13 | 131,641 | 2,386,125 | 8,431,320 | 8.3 M to 8.4 M (+1.59 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.78 | 54,025 | 960,727 | 8,299,679 | 8.2 M to 8.3 M (+0.66 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.74 | 157,601 | 2,795,180 | 8,245,654 | 8.1 M to 8.2 M (+1.95 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.58 | 13,143 | 231,109 | 8,088,053 | 8.1 M to 8.1 M (+0.16 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.43 | 63,151 | 1,100,469 | 8,074,910 | 8 M to 8.1 M (+0.79 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.13 | 1,103 | 19,997 | 272,995 | 271.9 K to 273 K (+0.41 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.13 | 5,184 | 93,965 | 271,892 | 266.7 K to 271.9 K (+1.94 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.78 | 2,147 | 38,180 | 266,708 | 264.6 K to 266.7 K (+0.81 %) |